Magnesium glycinate
CAS No. 14783-68-7
Magnesium glycinate( —— )
Catalog No. M18043 CAS No. 14783-68-7
Magnesium glycinate is a supplement that boost magnesium levels in people with a deficiency of the mineral.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | 27 | In Stock |
|
Biological Information
-
Product NameMagnesium glycinate
-
NoteResearch use only, not for human use.
-
Brief DescriptionMagnesium glycinate is a supplement that boost magnesium levels in people with a deficiency of the mineral.
-
DescriptionMagnesium glycinate is a supplement that boost magnesium levels in people with a deficiency of the mineral. Magnesium is a vital nutrient for regulating many body processes, including muscle and nerve function, blood sugar levels, and blood pressure. This mineral also supports the making of protein, bone, and DNA.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number14783-68-7
-
Formula Weight172.42
-
Molecular FormulaC4H8MgN2O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : 2 mg/mL (11.60 mM)
-
SMILES[Mg++].NCC([O-])=O.NCC([O-])=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Schwalfenberg GK,etal.The Importance of Magnesium in Clinical Healthcare.Scientifica (Cairo). 2017;2017:4179326.
molnova catalog
related products
-
WRW4 TFA(878557-55-2...
Selective antagonist of formyl peptide receptor 2 (FPR2) signaling. Inhibits WKYMVm binding to FPR2 (IC50 = 0.23 μM) and inhibits intracellular calcium release induced by WKYMVm, MMK 1, amyloid β42, and F peptide. Also inhibits FPR2-mediated signaling in human neutrophils; blocks chemotactic migration and superoxide generation by amyloid β42 peptide.
-
Propiverine hydrochl...
Propiverine is a widely used antimuscarinic drug with a mixed mode of action in the treatment of symptoms associated with overactive bladder (OAB).
-
Thiazolidinone-Deriv...
Thiazolidinone-Derivatives-1 inhibits the secretion of gastric acid and can be used in research on the treatment of gastric and duodenal ulcers.
Cart
sales@molnova.com